Miki Horiguchi
1 appearance in the program
Sessions & presentations
Innovative Methods in Oncology Clinical Trials
Speaker
Presentation: Assessing Survival Benefits of Immunotherapy Using Long-Term Average Hazard
Contributed Papers · Wed, Aug 7 , 10:30 AM